試す - 無料

TeleHealth: Rapid growth ahead

Healthcare Radius

|

September 2022

Driven by a need to reach out to patients for care delivery during the pandemic, TeleHealth has emerged as the fastest-growing space within the healthcare sector in India. Explore the adoption levels, growth drivers, emergence of new opportunities, and nuances of growth in this special feature

- NAGESH JOSHI

TeleHealth: Rapid growth ahead

Growth and higher growth' has been the story of India's remote delivery of healthcare services market, also known as TeleHealth. According to industry observers, the growth in the TeleHealth space in India has been more than a hundred percent, if not higher, during the past two years.

The trend looks no different when we compare it with the global market. According to a report by MarketsandMarkets, the worldwide TeleHealth and telemedicine market is expected to reach $285.7 billion by 2027, growing by a compounded annual growth rate of 26.6 percent. The factors driving this growth include the rising population, increasing need to expand healthcare access, growing prevalence of chronic diseases and conditions, shortage of physicians, advancements in telecommunications, rising government support, and growing awareness. Interestingly, each of the above factors applies to India, indicating considerable growth for TeleHealth.

Adoption of TeleHealth in India

Although TeleHealth existed well before the pandemic, it was during the pandemic era that it witnessed substantial growth. When patients could not leave their homes due to lockdown, India's healthcare service providers reached out to them remotely via TeleHealth.

"In India, the growth of TeleHealth is driven by increasing acceptability among people, ease of use, convenience, low cost, and widespread internet availability. The absence of good doctors and medical specialists in rural areas is another factor popularizing TeleHealth in the hinterland," comments Ajay Sharma, Co-founder and COO, DESH Clinic, Delhi. DESH Clinic, a health-tech company, operates 100 digitally enabled smart health (DESH) clinics in rural and semi-urban areas across India.

Healthcare Radius からのその他のストーリー

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Translate

Share

-
+

Change font size